Sign inGet started

Ahn Chang Ho

Insider CIK 1316420 · RNN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
RNN REXAHN PHARMACEUTICALS, IN M Exercise deriv2017-04-102017-04-12250,000— $00SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise2017-04-102017-04-12250,000$0.31 $77.5K6,260,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN S Sale2017-04-102017-04-12250,000$0.70 $175.0K6,010,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2017-01-202017-01-24330,000— $0330,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2017-01-202017-01-2470,000— $070,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2016-01-282016-02-01214,461— $0214,461SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2016-01-282016-02-01200,000— $0200,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2015-01-232015-01-27333,332— $0333,332SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise deriv2015-01-122015-01-1248,444— $0549,151SEC↗
RNN REXAHN PHARMACEUTICALS, IN S Sale2015-01-122015-01-1248,444$0.91 $44.1K6,010,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise2015-01-122015-01-1248,444$0.80 $38.8K6,058,444SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise deriv2015-01-092015-01-12186,212— $0597,595SEC↗
RNN REXAHN PHARMACEUTICALS, IN S Sale2015-01-092015-01-12186,212$0.92 $171.3K6,010,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise2015-01-092015-01-12186,212$0.80 $149.0K6,196,212SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise deriv2015-01-082015-01-1280,000— $0783,807SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise2015-01-082015-01-1280,000$0.80 $64.0K6,090,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN S Sale2015-01-082015-01-1280,000$0.90 $72.0K6,010,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN G Gift2014-12-182014-12-22803,924— $06,010,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise deriv2014-06-122014-06-16136,193— $0863,807SEC↗
RNN REXAHN PHARMACEUTICALS, IN M Exercise2014-06-122014-06-16136,193$0.80 $109.0K6,950,117SEC↗
RNN REXAHN PHARMACEUTICALS, IN S Sale2014-06-122014-06-16136,193$0.99 $134.8K6,813,924SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2014-01-122014-01-14125,000— $0125,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2013-03-012013-03-05250,000— $0250,000SEC↗